CBRE vs. Newmark: Which Real Estate Stock Is a Better Buy in 2026?

CBRE reported FY2025 revenue of nearly $40.6 billion, up 13.4%, with $1.3 billion in net income and $1.2 billion in free cash flow, while Newmark posted faster FY2025 revenue growth of 20.3% to $3.3 billion and net income of $126.2 million. The article argues Newmark is more attractive on valuation, with a 7.8x forward P/E and 0.7x P/S versus CBRE’s 17.6x and 1.0x, and highlights Newmark’s 1.6% dividend yield. Overall tone is constructive on Newmark relative to CBRE, though the piece remains primarily comparative and opinion-based.

Analysis

CBRE’s scale is not just defensive; it is a compounding asset in a slow-growth transaction environment because it can monetize market share when smaller brokers are forced to retrench. The cleaner read-through is that any downturn in office or investment sales volume likely compresses mid-tier competitors harder than the platform leaders, so the relative winner is the firm with the deepest client wallet share and the broadest ancillary services mix. That said, the market is already rewarding the “quality at scale” narrative less than it should, which creates room for a re-rating if rate volatility eases and cap rates stabilize over the next 2-3 quarters.

Newmark’s faster top-line growth is real, but the quality of that growth matters more than the headline. Heavy stock-based compensation dilutes the economic value of reported cash flow, so the apparent cash conversion is less durable than it looks; in a weaker transaction tape, that can quickly turn from a growth story into a margin story. The second-order risk is that aggressive comp and incentives may be masking underlying competitive pressure versus the larger platforms, which means the earnings power is more cyclical than the valuation multiple suggests.

The market’s consensus seems too focused on near-term valuation gaps and not enough on persistence of earnings power. If rates stay higher for longer, both names benefit from scarcity of balance-sheet stress relative to smaller private brokers, but CBRE has the better operating leverage to advisory recoveries while Newmark has more downside if volumes roll over again. The catalyst path is months, not days: watch for transaction volume inflection, financing spreads, and management commentary on retention/comp, because those will determine whether Newmark’s growth can outpace dilution and whether CBRE’s discount closes.

My base case is that the better relative trade is long CBRE / short NMRK on a 6-12 month horizon, because the market is underpricing durability versus growth. If the sector weakens again, CBRE should hold up better on mix and scale, while Newmark’s lower multiple may not protect it if revenue growth decelerates. The contrarian angle is that CBRE’s selloff may already have discounted the pension/earnings noise, making it the higher-quality rebound candidate once macro visibility improves.

Key Decisions for Investors

• Go long CBRE / short NMRK as a 6-12 month pair trade; target relative outperformance if CRE activity stays weak and investors rotate toward durable earnings quality.
• Accumulate CBRE on any further 3-5% pullback over the next 2-4 weeks; use a 10-15% upside target on a normalization of sentiment and a tighter spread to sector leaders.
• Avoid chasing NMRK on valuation alone; wait for evidence that revenue growth remains >15% while stock-based compensation trends below operating cash flow, otherwise the multiple is a value trap.
• For options-oriented accounts, consider a bullish CBRE call spread 3-6 months out to express mean reversion with defined downside, funded by a small NMRK put spread if transaction data softens.